Lois Chandler

Chief Operating Officer at

Taxus Cardium Pharmaceuticals Group, Inc.

Consumer Services

Health Technology

Profile

Lois A. Chandler is currently the Chief Operating Officer at Taxus Cardium Pharmaceuticals Group, Inc. She previously worked as the Vice President-Product Development at Activation Therapeutics, Inc. from 2006 to 2019.
Dr. Chandler completed her undergraduate degree at Stanford University and holds a doctorate from the University of Southern California.

Lois Chandler active positions

Companies	Position	Start
Taxus Cardium Pharmaceuticals Group, Inc. Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease	Chief Operating Officer	01/07/2019

All active positions of Lois Chandler

Former positions of Lois Chandler

Companies	Position	End
Activation Therapeutics, Inc. Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops late-stage clinical and commercial development of regenerative medicine therapeutics	Corporate Officer/Principal	01/01/2019

See the detail of Lois Chandler's experience

Training of Lois Chandler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lois Chandler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Southern California University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Taxus Cardium Pharmaceuticals Group, Inc. Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease	Health Technology
Activation Therapeutics, Inc. Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops late-stage clinical and commercial development of regenerative medicine therapeutics	Health Technology